Sign in

CIK 0001869105 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

BridgeBio Oncology Therapeutics, Inc.

Sign in to watch
Ticker
BBOT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
857 702 0377
Business address
256 E. GRAND AVENUE, SUITE 104, SOUTH SAN FRANCISCO, CA, 94080
Former names
Helix Acquisition Corp. II
  1. S-1 Offering Registration Statement
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. EFFECT Other Notice of Effectiveness
  10. SCHEDULE 13G Stake Statement of Beneficial Ownership
  11. SCHEDULE 13D Stake Beneficial Ownership Report
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 5 of 10 · 187 filings